T1D Fund
The T1D Fund
◆ Investment Thesis
Focus on accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes through equity investments in companies pursuing disease-modifying or curative potential.
◆ About The T1D Fund
The T1D Fund is an impact investment fund and venture philanthropy affiliate of Breakthrough T1D, focused exclusively on accelerating treatments, preventions, and cures for type 1 diabetes (T1D) through equity investments in early-stage biotech companies. It co-invests with venture capital, biopharma, and foundations in a modality-agnostic approach across autoimmune therapies, cell replacement, regeneration, and metabolic control. All returns are recycled into new T1D investments to maximize philanthropic impact.
◆ Sectors
◆ Stages
◆ Geography Focus
◆ Notable Investments
◆ Traits
Leads rounds
Co-invests
◆ FAQ
What does T1D Fund invest in?
T1D Fund invests in Biotech, Drug Discovery, Medtech and Digital Health at the seed stage.
Which geographies does T1D Fund focus on?
T1D Fund focuses on global, and is headquartered in USA.
What is T1D Fund's typical check size?
T1D Fund typically writes checks of $1M to $10M.